scholarly journals Association of Carboxyhemoglobin Levels with Peripheral Arterial Disease in Chronic Smokers Managed at Dr George Mukhari Academic Hospital

Author(s):  
Mashudu Nemukula ◽  
Motetelo Alfred Mogale ◽  
Honey Bridget Mkhondo ◽  
Lizette Bekker

Chronic cigarette smokers (CCS) are known to have elevated levels of carboxyhemoglobin (COHb). However, it is not known whether increased levels of COHb are associated with endothelial dysfunction (ED), and therefore the development of peripheral arterial disease (PAD). The aim of the study was to investigate the association of blood COHb and plasma nitric oxide (NO) levels, and whether it is an independent risk factor in the development of PAD among CCS at Dr George Mukhari Academic Hospital (DGMAH). A sample of 120 CCS with PAD and a convenience sample of 100 CCS without PAD were recruited into the study. Blood COHb levels were measured using the ABL 90 FLEX CO-oximeter automated spectroscopy. Plasma nitric oxide (NO) levels were measure using ELISA. Logistic regression analysis was used to investigate the association of blood COHb and plasma NO with PAD. Blood COHb levels of CCS with PAD were significantly higher than those of CCS without PAD, and the NO levels of CCS with PAD were significantly lower than those of CCS without PAD. Although both the blood COHb and plasma NO in CCS were significantly associated with PAD in bivariate logistic analysis, only plasma NO was independently associated with PAD in multivariate logistic analysis. This finding is consistent with the hypothesis that COHb is a cause of arterial damage in PAD, leading to reduced NO, and therefore reduced arterial dilation.

2006 ◽  
Vol 44 (3) ◽  
pp. 525-530 ◽  
Author(s):  
Lorenzo Loffredo ◽  
Pasquale Pignatelli ◽  
Roberto Cangemi ◽  
Paola Andreozzi ◽  
Maria Antonietta Panico ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Gareth Williams ◽  
Xu Shi-Wen ◽  
David Abraham ◽  
Sadasivam Selvakumar ◽  
Daryll M. Baker ◽  
...  

Peripheral Arterial Disease (PAD) is a cause of significant morbidity and mortality in the Western world. Risk factor modification and endovascular and surgical revascularisation are the main treatment options at present. However, a significant number of patients still require major amputation. There is evidence that nitric oxide (NO) and its endogenous inhibitor asymmetric dimethylarginine (ADMA) play significant roles in the pathophysiology of PAD. This paper reviews experimental work implicating the ADMA-DDAH-NO pathway in PAD, focussing on both the vascular dysfunction and effects within the ischaemic muscle, and examines the potential of manipulating this pathway as a novel adjunct therapy in PAD.


2017 ◽  
Vol 65 (2) ◽  
pp. 151-162 ◽  
Author(s):  
Muzaffer Akkoca ◽  
Suzan Emel Usanmaz ◽  
Cuneyt Koksoy ◽  
Ugur Bengisun ◽  
Emine Demirel-Yilmaz

2009 ◽  
Vol 9 (1) ◽  
pp. 107-112 ◽  
Author(s):  
Joaquin de Haro Miralles ◽  
Esther Martínez-Aguilar ◽  
Aurora Florez ◽  
César Varela ◽  
Silvia Bleda ◽  
...  

2009 ◽  
Vol 96 (S1) ◽  
pp. 3-3
Author(s):  
K. J. Dickinson ◽  
R Riba ◽  
C. Irwin ◽  
K. Naseem ◽  
S. Homer-Vanniasinkam

Sign in / Sign up

Export Citation Format

Share Document